ACBI-4
ACBI-4 is a selective PROTAC degrader targeting the active state of GTP-loaded KRAS (KRAS (on) ) . It demonstrates significant antiproliferative effects and effectively degrades various KRAS mutants in cancer cells, such as KRASG12R.
Product Specifications
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog